Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City, 33358-33359 [2021-13252]
Download as PDF
<![CDATA[
33358
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 60-Day notice.
form. The proposed IC is also being
published to obtain comments from the
public and affected agencies.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 23, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
regarding the estimated public burden
or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions, or
additional information, please contact:
Neil Troppman, Law Enforcement
Support Branch, National Tracing
Center Division, either by mail at 244
Needy Road, Martinsburg, WV 25405,
by email at neil.troppman@atf.gov, or by
telephone at 304–260–3643.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
The Bureau of Alcohol,
Tobacco, Firearms and Explosives
(ATF), Department of Justice (DOJ), will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
(IC) OMB 1140–0003 (Report of
Multiple Sale or Other Disposition of
Pistols and Revolvers—ATF Form
3310.4) is being revised due to an
increase in the total respondents,
responses, and burden hours. A minor
change to update the firearms
description columns was made to the
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Revision of a currently approved
collection.
2. The Title of the Form/Collection:
Report of Multiple Sale or Other
Disposition of Pistols and Revolvers.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): ATF
Form 3310.4.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 731–TA–1546–1549
(Final)]
Thermal Paper From Germany, Japan,
Korea, and Spain; Notice of Correction
Concerning Scheduling of Record
Closing and Final Comments
United States International
Trade Commission.
ACTION: Correction of notice.
AGENCY:
Correction is made to the
October 20, 2021 date of record closing,
and the October 22, 2021 deadline for
filing final comments, in the Written
Submissions section of the notice which
was published on June 9, 2021 (86 FR
30627). The correct deadline dates are
as follows: The record closing is October
19, 2021; and deadline for final
comments is October 21, 2021.
SUMMARY:
By order of the Commission.
Issued: June 14, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–13345 Filed 6–23–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms
and Explosives
[OMB Number 1140–0003]
Agency Information Collection
Activities; Proposed eCollection of
eComments Requested; Revision of a
Currently Approved Collection; Report
of Multiple Sale or Other Disposition of
Pistols and Revolvers—ATF Form
3310.4
AGENCY:
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:19 Jun 23, 2021
Jkt 253001
PO 00000
Frm 00153
Fmt 4703
Sfmt 4703
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other (if applicable): Federal
Government and State, Local, or Tribal
Government.
Abstract: The Report of Multiple Sale
or Other Disposition of Pistols and
Revolvers—ATF Form 3310.4 is used to
report multiple sale or other disposition
of two or more pistols, revolvers, or any
combination of pistols or revolvers to an
unlicensed person, whether it occurs
one time or within five consecutive
business days.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 82,011
respondents will complete this form
approximately 6.33365 times annually,
and it will take each respondent
approximately 15 minutes to complete
their responses.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
129,857 hours, which is equal to 82,011
(# of respondents) * 6.33365 (# of
responses per respondent) * .25 (15
mins).
7. An Explanation of the Change in
Estimates: The increase in total
respondents, responses, and burden
hours, by 4,106, 63,495, and 15,873
hours respectively, is due to the revision
of agency estimates, and a general
increase in the number of respondents
since the last renewal in 2018.
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Dated: June 21, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2021–13419 Filed 6–23–21; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–857]
Bulk Manufacturer of Controlled
Substances Application: Cambrex
Charles City
Drug Enforcement
Administration, Justice.
AGENCY:
E:\FR\FM\24JNN1.SGM
24JNN1
33359
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
ACTION:
Notice of application.
Cambrex Charles City has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on May 6, 2021, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Controlled substance
khammond on DSKJM1Z7X2PROD with NOTICES
Gamma Hydroxybutyric
Acid .............................
Tetrahydrocannabinols ...
Amphetamine ..................
Lisdexamfetamine ...........
Methylphenidate .............
ANPP (4-Anilino-Nphenethyl-4-piperidine)
Phenylacetone ................
Codeine ..........................
Oxycodone ......................
Hydromorphone ..............
Hydrocodone ..................
Methadone ......................
Morphine .........................
Oripavine ........................
Thebaine .........................
Opium extracts ...............
Opium fluid extract .........
Opium tincture ................
Opium, powdered ...........
Oxymorphone .................
Noroxymorphone ............
Fentanyl ..........................
Drug
code
Schedule
2010
7370
1100
1205
1724
I
I
II
II
II
8333
8501
9050
9143
9150
9193
9250
9300
9330
9333
9610
9620
9630
9639
9652
9668
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
19:19 Jun 23, 2021
Jkt 253001
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–13252 Filed 6–23–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–858]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Annac
Medical Center LC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket
No—DEA–858 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
DATES:
The company plans to manufacture
the above-listed controlled substances
in bulk for conversion to other
controlled substances and sales to its
customers for dosage form development,
clinical trials and use in stability
qualification studies. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture this drug as
synthetic. No other activities for these
VerDate Sep<11>2014
drug codes are authorized for this
registration.
PO 00000
Frm 00154
Fmt 4703
Sfmt 4703
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). In addition
to seeking to produce marihuana
extract, this applicant is separately
seeking to cultivate marihuana. See
Notice of Application, Bulk
Manufacturers of Marihuana, 84 FR
44920, 44922 (Aug. 27, 2019). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on April 14, 2021, Annac Medical
Center, LC, 5172 West Patrick Lane,
Suite 100, Las Vegas, Nevada 89117–
8911, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
Controlled substance
Tetrahydrocannabinols ...
Drug
code
Schedule
I 7370 II
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–13249 Filed 6–23–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Oil
Pollution Act
On June 17, 2021, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Western District of
Louisiana in the lawsuit entitled United
States of America and Louisiana v.
CITGO Petroleum Corp., Civil Action
No. 2:21–cv–1705. The United States is
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 86, Number 119 (Thursday, June 24, 2021)]
[Notices]
[Pages 33358-33359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13252]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-857]
Bulk Manufacturer of Controlled Substances Application: Cambrex
Charles City
AGENCY: Drug Enforcement Administration, Justice.
[[Page 33359]]
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambrex Charles City has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 23, 2021.
Such persons may also file a written request for a hearing on the
application on or before August 23, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 6, 2021, Cambrex Charles City, 1205 11th Street,
Charles City, Iowa 50616-3466, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid........................... 2010 I
Tetrahydrocannabinols............................... 7370 I
Amphetamine......................................... 1100 II
Lisdexamfetamine.................................... 1205 II
Methylphenidate..................................... 1724 II
ANPP (4-Anilino-N-phenethyl-4-piperidine)........... 8333 II
Phenylacetone....................................... 8501 II
Codeine............................................. 9050 II
Oxycodone........................................... 9143 II
Hydromorphone....................................... 9150 II
Hydrocodone......................................... 9193 II
Methadone........................................... 9250 II
Morphine............................................ 9300 II
Oripavine........................................... 9330 II
Thebaine............................................ 9333 II
Opium extracts...................................... 9610 II
Opium fluid extract................................. 9620 II
Opium tincture...................................... 9630 II
Opium, powdered..................................... 9639 II
Oxymorphone......................................... 9652 II
Noroxymorphone...................................... 9668 II
Fentanyl............................................ 9801 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for conversion to other controlled substances and
sales to its customers for dosage form development, clinical trials and
use in stability qualification studies. In reference to drug code 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture this
drug as synthetic. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-13252 Filed 6-23-21; 8:45 am]
BILLING CODE P
